Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bonora

Showing results (221-230 of 302) with videos related to

Pageof 31
Sort By:
AIDS (London, England)|February 1, 2024
Lower aids-related hospitalizations in women living with HIV multidrug resistanceRebecka Papaioannu Borjesson, Laura Galli, Riccardo Lolatto, et al.
Current HIV Research|June 1, 2017
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative DisordersAndrea Calcagno, Anna Lucchini, Daniele Caracciolo, et al.
The Journal of Antimicrobial Chemotherapy|September 9, 2008
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver diseaseGiovanni Guaraldi, Stefania Cocchi, Alice Motta, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale ScreeningAmedeo De Nicolò, Valeria Avataneo, Jessica Cusato, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 20, 2016
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical settingLetizia Marinaro, Andrea Calcagno, Diego Ripamonti, et al.
Therapeutic Drug Monitoring|March 13, 2012
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical settingMarco Siccardi, Antonio DʼAvolio, Sonia Rodriguez-Novoa, et al.
Italian Journal of Dermatology and Venereology|January 18, 2023
Oral doxycycline in HIV-related synchronous malignant syphilis and condyloma lataGianluca Avallone, Francesco Cavallo, Sara Susca, et al.
International Journal of Antimicrobial Agents|February 4, 2021
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?Alice Trentalange, Enrica Borgogno, Ilaria Motta, et al.
AIDS Research and Human Retroviruses|July 14, 2015
HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated PatientsAndrea Calcagno, Ilaria Motta, Valeria Ghisetti, et al.
Journal of Clinical Microbiology|January 16, 2009
Molecular typing of Mycobacterium bovis strains isolated in Italy from 2000 to 2006 and evaluation of variable-number tandem repeats for geographically optimized genotypingM Beatrice Boniotti, Maria Goria, Daniela Loda, et al.
Pageof 31

Showing results (221-230 of 302) with videos related to

Sort By:
Pageof 31
AIDS (London, England)|February 1, 2024
Lower aids-related hospitalizations in women living with HIV multidrug resistanceRebecka Papaioannu Borjesson, Laura Galli, Riccardo Lolatto, et al.
Current HIV Research|June 1, 2017
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative DisordersAndrea Calcagno, Anna Lucchini, Daniele Caracciolo, et al.
The Journal of Antimicrobial Chemotherapy|September 9, 2008
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver diseaseGiovanni Guaraldi, Stefania Cocchi, Alice Motta, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale ScreeningAmedeo De Nicolò, Valeria Avataneo, Jessica Cusato, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 20, 2016
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical settingLetizia Marinaro, Andrea Calcagno, Diego Ripamonti, et al.
Therapeutic Drug Monitoring|March 13, 2012
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical settingMarco Siccardi, Antonio DʼAvolio, Sonia Rodriguez-Novoa, et al.
Italian Journal of Dermatology and Venereology|January 18, 2023
Oral doxycycline in HIV-related synchronous malignant syphilis and condyloma lataGianluca Avallone, Francesco Cavallo, Sara Susca, et al.
International Journal of Antimicrobial Agents|February 4, 2021
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?Alice Trentalange, Enrica Borgogno, Ilaria Motta, et al.
AIDS Research and Human Retroviruses|July 14, 2015
HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated PatientsAndrea Calcagno, Ilaria Motta, Valeria Ghisetti, et al.
Journal of Clinical Microbiology|January 16, 2009
Molecular typing of Mycobacterium bovis strains isolated in Italy from 2000 to 2006 and evaluation of variable-number tandem repeats for geographically optimized genotypingM Beatrice Boniotti, Maria Goria, Daniela Loda, et al.
Pageof 31